Results 91 to 100 of about 7,381 (220)
Targeting the cancer kinome through polypharmacology [PDF]
Nature Reviews Cancer, 2010 Kinase inhibitors are the largest class of new cancer drugs. However, it is already apparent that most tumours can escape from the inhibition of any single kinase. If it is necessary to inhibit multiple kinases, how do we choose which ones? In this Opinion article, we discuss some of the strategies that are currently being used to identify new ...
Zachary A, Knight +2 more
openaire +2 more sources
C-SPADE : a web-tool for interactive analysis and visualization of drug screening experiments through compound-specific bioactivity dendrograms [PDF]
, 2017 The advent of polypharmacology paradigm in drug discovery calls for novel chemoinformatic tools for analyzing compounds' multi-targeting activities.
Aittokallio, Tero +3 more
core +1 more source
Health Science Reports, Volume 9, Issue 3, March 2026.ABSTRACT Background and Aims De novo drug design is the process of generating novel lead compounds that possess desirable pharmacological activities and optimal physicochemical properties for therapeutic development. In recent years, it has evolved into a key computational strategy for discovering and optimizing new therapeutic compounds. Reinforcement
Masuda Begum Sampa +1 more
wiley +1 more source
Molecules, 2020 A series of 27 compounds of general structure 2,3-dihydro-benzo[1,4]oxazin-4-yl)-2-{4-[3-(1H-3indolyl)-propyl]-1-piperazinyl}-ethanamides, Series I: 7(a–o) and (2-{4-[3-(1H-3-indolyl)-propyl]-1-piperazinyl}-acetylamine)-N-(2-morfolin-4-yl-ethyl ...
Christopher Cerda-Cavieres +13 more
doaj +1 more source
Scalable Similarity Search for Molecular Descriptors
, 2017 Similarity search over chemical compound databases is a fundamental task in the discovery and design of novel drug-like molecules. Such databases often encode molecules as non-negative integer vectors, called molecular descriptors, which represent rich ...
A Leach +11 more
core +1 more source
The p110 delta structure: mechanisms for selectivity and potency of new PI(3)K inhibitors. [PDF]
, 2010 Deregulation of the phosphoinositide-3-OH kinase (PI(3)K) pathway has been implicated in numerous pathologies including cancer, diabetes, thrombosis, rheumatoid arthritis and asthma.
Alex Berndt +16 more
core +2 more sources
Journal of Biochemical and Molecular Toxicology, Volume 40, Issue 3, March 2026.Imidazole alkaloids epiisopilosine and epiisopiloturine protect the liver against acetaminophen‐induced toxicity by reducing oxidative stress, suppressing inflammatory mediators, and restoring antioxidant defenses. These hepatoprotective effects are partially mediated by enhanced autophagy, indicating a key mechanistic pathway for the biological ...
Ana Patricia de Oliveira +19 more
wiley +1 more source
RegenBase: a knowledge base of spinal cord injury biology for translational research. [PDF]
, 2016 Spinal cord injury (SCI) research is a data-rich field that aims to identify the biological mechanisms resulting in loss of function and mobility after SCI, as well as develop therapies that promote recovery after injury.
Abeyruwan, Saminda W +9 more
core +2 more sources
Journal of Intelligent Medicine, Volume 3, Issue 1, Page 26-46, March 2026.Abstract Kinase inhibitors are essential in targeted cancer therapy, yet resistance often emerges through secondary mutations, activation of compensatory signaling pathways, or drug‐efflux mechanisms. Artificial intelligence (AI) provides a workflow‐based strategy rather than a list of unrelated tools for predicting and addressing kinase‐inhibitor ...
Faris Hassan +3 more
wiley +1 more source
Cytoneme-mediated signaling essential for tumorigenesis. [PDF]
, 2019 Communication between neoplastic cells and cells of their microenvironment is critical to cancer progression. To investigate the role of cytoneme-mediated signaling as a mechanism for distributing growth factor signaling proteins between tumor and tumor ...
Fereres, Sol +3 more
core +1 more source